[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 727 Introduced in Senate (IS)]

<DOC>






118th CONGRESS
  1st Session
                                 S. 727

        To limit the price charged by manufacturers for insulin.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             March 9, 2023

 Mr. Sanders (for himself, Mr. Merkley, and Mr. Markey) introduced the 
 following bill; which was read twice and referred to the Committee on 
                 Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
        To limit the price charged by manufacturers for insulin.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Insulin for All Act of 2023''.

SEC. 2. LIMITATION ON PRICE OF INSULIN.

    (a) In General.--Notwithstanding any other provision of law, the 
price charged by manufacturers of insulin for insulin that is sold in 
the United States may not exceed $20 per 1000 units of insulin, which 
may be contained in one or more vials, pens, cartridges, or other forms 
of delivery.
    (b) Insulin Defined.--In this section, the term ``insulin'' means 
insulin that is licensed under subsection (a) or (k) of section 351 of 
the Public Health Service Act (42 U.S.C. 262) and continues to be 
marketed pursuant to such licensure.
                                 <all>